Stock Events

Uluru 

$0
2
+$0+0% Tuesday 15:32

Statistics

Day High
0
Day Low
0
52W High
0
52W Low
0
Volume
1,290
Avg. Volume
-
Mkt Cap
5.35M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

15NovExpected
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
0
0.33
0.67
1
Expected EPS
0
Actual EPS
0

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ULUR. It's not an investment recommendation.
Alphabet
78395
GOOGL
Apple
68177
AAPL
Microsoft
63621
MSFT
Amazon
59331
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap399.26B
Johnson & Johnson, through its subsidiaries, develops and sells a wide range of healthcare products, overlapping with Uluru's wound care and biotechnology products.
Pfizer
PFE
Mkt Cap164.39B
Pfizer Inc. operates in the biopharmaceutical industry producing medicines and vaccines, directly competing in the healthcare sector similar to Uluru.
Merck
MRK
Mkt Cap300.25B
Merck & Co., Inc. is a global healthcare company that offers health solutions, including wound care and management, which competes with Uluru's product offerings.
Abbott Laboratories
ABT
Mkt Cap197.08B
Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products, competing in similar markets as Uluru.
Bristol-Myers Squibb
BMY
Mkt Cap101.27B
Bristol-Myers Squibb Company, a biopharmaceutical company, develops and markets drugs in areas overlapping with Uluru's therapeutic sectors.
Lilly(Eli) &
LLY
Mkt Cap864.43B
Eli Lilly and Company focuses on pharmaceutical products and has initiatives in biomedicine, directly competing with some of Uluru's biotechnological advancements.
GSK
GSK
Mkt Cap89.55B
GlaxoSmithKline plc is a healthcare company that researches and develops pharmaceuticals, vaccines, and health-related consumer products, competing in the same industry as Uluru.
Novartis
NVS
Mkt Cap244.75B
Novartis AG provides healthcare solutions that compete with Uluru in terms of pharmaceuticals and biotechnological research in healthcare.
Sanofi
SNY
Mkt Cap141.43B
Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions, competing with Uluru in the pharmaceutical and biotech sectors.
Astrazeneca
AZN
Mkt Cap271.67B
AstraZeneca PLC, a biopharmaceutical company, develops products in various therapy areas that are similar to Uluru's, making it a direct competitor.

About

Pharmaceuticals: Other
Health Technology
Pharmaceuticals: Major
Manufacturing
Pharmaceutical Preparation Manufacturing
Show more...
CEO
Country
US
ISIN
US90403T3086

Listings